Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.
Emily Diseroad, PharmD, BCPPS
Advertisement
Emily Diseroad is an intensive care unit float clinical pharmacy specialist at Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio. She has nothing to disclose.
Articles by Emily Diseroad, PharmD, BCPPS
Advertisement
Latest Updated Articles
Harmful excipients for pediatric patientsPublished: February 11th 2022 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Olivia Kim-McManus, MD, discusses genetic testing, therapy in pediatric neurology
2
FDA expands antithrombin III (human) label to pediatric patients with rare blood-clotting disorder
3
FDA accepts roflumilast cream 0.3% sNDA to treat plaque psoriasis in children 2 to 5 years
4
Roflumilast Efficacy and Safety in Pediatric AD
5
